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Abstract
Upon activation, B cells divide, form a germinal center, and express the activation induced deaminase (AID), an enzyme that
triggers somatic hypermutation of the variable regions of immunoglobulin (Ig) loci. Recent evidence indicates that at least
25% of expressed genes in germinal center B cells are mutated or deaminated by AID. One of the most deaminated genes,
c-Myc, frequently appears as a translocation partner with the Ig heavy chain gene (Igh) in mouse plasmacytomas and human
Burkitt’s lymphomas. This indicates that the two genes or their double-strand break ends come into close proximity at
a biologically relevant frequency. However, the proximity of c-Myc and Igh has never been measured in germinal center B
cells, where many such translocations are thought to occur. We hypothesized that in germinal center B cells, not only is c-
Myc near Igh, but other mutating non-Ig genes are deaminated by AID because they are near Ig genes, the primary targets
of AID. We tested this ‘‘collateral damage’’ model using 3D-fluorescence in situ hybridization (3D-FISH) to measure the
distance from non-Ig genes to Ig genes in germinal center B cells. We also made mice transgenic for human MYC and
measured expression and mutation of the transgenes. We found that there is no correlation between proximity to Ig genes
and levels of AID targeting or gene mutation, and that c-Myc was not closer to Igh than were other non-Ig genes. In
addition, the human MYC transgenes did not accumulate mutations and were not deaminated by AID. We conclude that
proximity to Ig loci is unlikely to be a major determinant of AID targeting or mutation of non-Ig genes, and that the MYC
transgenes are either missing important regulatory elements that allow mutation or are unable to mutate because their new
nuclear position is not conducive to AID deamination.
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Introduction
In mice and humans, antibodies are produced by B cells and are
composed of two light chains, coded for by either Igk or Igl, and
two heavy chains, coded for by Igh. Each of the heavy and light
chains consist of a variable region, which binds antigen and varies
from B cell to B cell, and a constant region, whose sequence does
not change for a given antibody isotype. There are several
different Igh constant regions, conferring different effector func-
tions, and the B cell can undergo class switch recombination
(CSR), a rearrangement of germline DNA, to switch from one
constant region to another. The regions of DNA that break during
CSR are called switch regions and, with the exception of IgD,
every constant region has its own upstream switch region [1].
Both CSR and somatic hypermutation (SHM) are initiated by
and dependent on the enzyme Activation Induced Cytidine
Deaminase (AID). After a mature B cell is activated by pathogen
recognition and T cell interaction, it divides in the spleen or lymph
node and can contribute to the formation of a cluster of cells called
a germinal center (GC). GC B cells express AID, which
deaminates deoxycytidine in the variable region and switch region
DNA, thereby generating deoxyuracil:deoxyguanine (dU:dG)
mismatches. The dU:dG lesions can then be recognized by the
base excision repair protein Uracil DNA Glycosylase (UNG) and
the mismatch repair proteins Msh2/6 [2,3].
Although UNG and Msh2/6 usually initiate high-fidelity lesion
repair, during SHM of variable regions in GC B cells they trigger
error-prone repair processes, thereby spreading and changing the
nature of the AID induced lesions and yielding a mutated variable
region [4]. During CSR, these same repair factors process the dU
residues introduced by AID in switch regions to create DNA
double-strand breaks, whose processing and rejoining leads to
CSR [5]. SHM is also associated with double strand breaks
[6,7,8]. Variable region hypermutation is of benefit to the
organism since it allows the generation of B cells with slightly
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39601altered variable regions and antigen specificity. Some of the new B
cells are likely to have a higher affinity for the invading pathogen
and such B cells are enriched for during the GC response in
a process known as affinity maturation.
AID is expressed at high levels only in GC B cells and targets
immunoglobulin gene variable and switch regions at a level far
higher than other genes, but AID mediated mutation is not limited
to Ig genes [9]. SHM has been observed in GC or memory B cells
in the human genes BCL6, CD95, CD79A, and CD79B
[10,11,12,13], and a recent study in mice found that more than
20% of a large panel of expressed genes in WT GC B cells were
mutated at a significant level [14]. Analysis of mutation in GC B
cells from Msh2
2/2Ung
2/2 double knockout mice, which show
the footprint of AID action since lesions can neither be repaired
nor spread to surrounding DNA, indicated that more than 50% of
the expressed genes analyzed were targeted by AID [14]. Since
this study found many genes whose mutation frequency was
significantly higher in Msh2
2/2Ung
2/2 GC B cells than in WT
GC B cells, the authors proposed that there are three groups of
genes: those not detectably deaminated by AID, those deaminated
by AID but repaired predominantly by high-fidelity processes, and
those deaminated by AID and further mutated by error-prone
repair pathways [9,14].
Despite the abundance of mutation in non-Ig genes, even the
most highly mutated non-Ig gene, Bcl6, mutates at a frequency 25
times lower than that of Igh [14]. AID action is largely targeted to
Ig variable and switch regions and the mechanism of this targeting
is not yet well understood. The Ig variable region sequence and
promoter are not critical for targeting [15,16,17], and a role for Ig
enhancers is uncertain since their effect is only obvious in
transgenes [18,19,20,21,22,23,24]. E2A proteins might be in-
volved in AID targeting since E-box motifs, the binding sites for
E2A proteins, accidentally incorporated into a transgene increased
the mutation of that transgene [25]. Finally, there might be some
role for histone modifications. Histone H4 acetylation and histone
3 lysine 9 trimethylation (H3K9me3) have been associated with
switch regions undergoing CSR and H3K9me3 might be involved
in tethering of AID to donor switch regions [26,27,28,29]. No
direct link has been established between a histone modification
and AID recruitment to variable regions, but phosphorylation of
serine 14 on histone 2B closely correlates with SHM and CSR,
being elevated in the variable and switch regions of actively
hypermutating GC B cells [30].
c-Myc, one of the genes found to be highly deaminated by AID
in mouse GC B cells, is a common translocation partner with Ig
genes in human and mouse. c-Myc-Igh translocations deregulate c-
Myc, thereby contributing to mouse plasmacytomas and human
Burkitt’s lymphomas [31,32,33,34,35,36]. It has been known for
some time that the Ig gene translocation break points are in
regions deaminated by AID; in humans, near Ig light chain
variable regions or an Igh switch region, and in mice, near an Igh
switch region [34,35,37,38,39,40,41,42,43,44,45,46,47,48]. Inter-
estingly, two studies found that the region of c-Myc deaminated by
AID is precisely the region of c-Myc breakpoints in plasmacytomas
and sporadic Burkitt’s lymphomas - the first exon and first intron
[14,49].
Not only are the c-Myc and Ig breaks in regions deaminated by
AID, but the translocations, and very likely the double strand
breaks that underlie them, are also strongly dependent on AID
[50,51,52]. Since translocations require both breakage and
proximity, one might predict that c-Myc and Igh are near one
another in the nucleus of GC B cells. In addition, another gene in
the Myc family, n-Myc, does not translocate with Igh normally, but
does so when moved to the c-Myc locus [53]. We expected that the
c-Myc locus is conducive to Igh translocations at least in part
because it is physically close to the Igh locus in cells expressing
AID. c-Myc and Igh have been shown to move together for a short
period of 5–10 minutes after ex-vivo stimulation of B cells [54],
well before these cells express AID, but there have not been any
studies assessing the proximity of the two genes in GC B cells, at
the time of physiological, high-level AID expression.
We further hypothesized that proximity to Ig genes, in addition
to influencing translocation frequency, plays a role in determining
the mutation frequency of non-Ig genes. Specifically, we consid-
ered a ‘‘collateral damage’’ model in which Ig genes are targeted
for high-level deamination and mutation, with the deamination
and mutation of non-Ig genes depending in part on their distance
to a mutating Ig gene. Indeed, it is known that a high level of AID
is present at Igh switch regions during CSR [55], and the same is
presumably true for other active Ig genes in GC B cells. A high
concentration of AID and other factors necessary for mutation at
Ig loci could increase the likelihood of mutation of nearby genes.
To test the role of relative nuclear position in SHM targeting,
we used 3D-fluorescence in situ hybridization (3D-FISH) to
determine the position of four genes deaminated by AID (Bcl6,
Cd83, Pim1, and c-Myc) and two non-mutated/non-deaminated
genes (b2mand Mef2b) relative to Igh and Igl in splenic murine
GC B cells. Our analysis also allowed us to test the model that Igh
and c-Myc are prone to translocate with one another because they
are in unusually close proximity in GC B cells. Further, we
generated two mouse lines transgenic for a bacterial artificial
chromosome (BAC) spanning the human MYC locus, bred the
transgenes onto the Msh2
2/2Ung
2/2 background, and assessed
whether MYC was deaminated by AID and in close proximity to
Igh in two new nuclear locations. Our results fail to reveal any
correlation between the propensity of a gene to undergo SHM or
deamination by AID and its proximity to a mutating Ig locus in
GC B cells. The mouse c-Myc locus was not found to reside closer
to Igh than the other loci analyzed, and the human MYC
transgenes, though expressed in most cells analyzed, did not
acquire mutations on either the WT or Msh2
2/2Ung
2/2
background. Our results do not support the collateral damage
model and indicate that stable and close association of a gene with
Igh or Igl in GC B cells is not necessary for mutation or targeting
by AID.
Results
Distance between Non-Ig Loci and Igh
We measured the distance between non-Ig genes of interest and
Ig genes in GC B cells by 3D-FISH using GC B cells isolated from
spleens of B1-8 heterozygous mice immunized 10 days prior with
the hapten NP conjugated to chicken gamma globulin (NP-CGG).
B1-8 mice carry a knocked-in pre-rearranged Igh allele that is able
to bind NP as long as a l1o rl3 light chain is expressed. The
number of B cells that respond to NP is therefore substantially
increased in B1-8 mice [56,57,58,59]. After sorting for GC cells 8–
16 days after NP immunization, we found that the greatest
number of GC cells was obtained from the mice day 10 post-
immunization (data not shown), and therefore used this time point
for most experiments.
To enrich for GC B cells before purification by cell sorting, we
negatively selected to remove non-B cells and some naı ¨ve B cells
(see Materials and Methods). GC B cells were then sorted based
on expression of B220, FAS, and binding to NIP, a hapten
similar to NP which is bound by NP responding B cells. Naı ¨ve B
cells, which were sorted from a spleen sample that had not been
through the negative selection, were B220
+ but FAS
lo and did
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shown in Figure S1.
Mutation analysis showed that the pattern of mutation in spleen
GC B cells is similar to that in GC B cells from Peyer’s patches of
5–8 month old mice (Figure S2, Table S1). Bcl6 is mutated more
than are other non-Ig genes, followed by Cd38 and c-Myc, all of
which are above the background mutation frequency previously
defined in AID-deficient GC B cells [14]. The mutation
frequencies in GC B cells from Peyer’s patch are higher than
those in spleen, presumably because the former have been
chronically stimulated by antigens in the gut.
We chose to use a 3D-FISH procedure that preserves the
nuclear architecture and leaves nuclei spherical rather than
flattened on the slide. This procedure also results in relatively
small fluorescent spots marking each allele, thereby increasing the
resolution of the analysis. We analyzed only cells in interphase,
with the entire nucleus visible in the frame, and with both alleles of
each gene marked by fluorescent probe (Figure 1A). In each
experiment, we assessed one gene of interest and one Ig gene, and
measured the distance from each allele of the gene of interest to
the nearest allele of the Ig gene (Figure 1B).
We chose to analyze two genes that mutate in WT mice (Bcl6
and Cd83), and two genes that are deaminated by AID but show
much higher mutation frequencies in Msh2
2/2Ung
2/2 double
knockout mice than in WT mice (c-Myc and Pim1). In a large
sequencing study, Bcl6 and Cd83 were the two most mutated non-
Ig genes in WT mice, and Bcl6, c-Myc, Pim1, and Cd83 were four of
the five most deaminated genes in Msh2
2/2Ung
2/2 double
knockout mice [14]. All of the genes are expressed in GC B cells,
though c-Myc is expressed only at low levels [60]. To determine
whether mutating or deaminated genes are closer to Ig genes than
are non-deaminated genes, we compared the distances measured
from each of the four deaminated genes and an Ig gene to those
measured from each of two non-deaminated genes (b2mand
Mef2b [14]) and an Ig gene. We also measured the distance
between Igl and Igh to assess whether mutating Ig genes cluster in
a single nuclear location.
The distance data for these six non-Ig genes relative to Igh in
GC B cells are quite similar to one another (Figure 1C and 1D).
Median distances are near 2.5 mm (Figure 1C, Table S2), and in
all cases less than 1% of the gene-of-interest alleles were within
0.5 mmo fa nIgh allele (Figure 1D). These observations were also
true of Igl-Igh distance measurements (Figure 1C and 1D). There
are some statistically significant differences between the datasets:
Cd83 and Pim1 are slightly closer and c-Myc is slightly farther from
Igh than is b2m(Table S3). However, no trend could be discerned
to suggest that non-mutating genes are generally farther from Igh
than are mutating genes.
We were primarily interested in the positions of the genes
relative to Ig genes in GC B cells, but we also wondered how and if
the distances might change in the transition from naı ¨ve to GC B
cell. For example, it was conceivable that, prior to antigen
activation, AID-deaminated genes were closer to Ig loci than were
non-deaminated genes, thereby predisposing them to AID action.
We therefore measured the distances from the genes of interest to
the nearest Igh allele in naı ¨ve B cells and looked for differences
between the deaminated and non-deaminated genes. Overall, the
results in naı ¨ve B cells were similar to those in GC B cells. Because
naı ¨ve B cells are smaller than GC B cells, all distances measured
were on average smaller and the percentage of measurements
within 1 mm were larger, but again AID deaminated genes were
not consistently closer to Igh than were non-deaminated genes
(Figure 1E and 1F, Tables S4 and S5).
It is interesting that of all the non-Ig genes studied, the one
farthest on average from Igh in GC B cells was c-Myc. Since many
c-Myc and Igh translocations are AID mediated [3,50,51,52], we
thought it possible that at some point during the time of AID
activation, c-Myc and Igh would tend to be near one another, and
that perhaps analysis at day 10 of the GC response had failed to
detect this. We therefore measured the distance between c-Myc and
Igh at other times in the GC response, starting at day 8 post-
immunization, which was the earliest that we could collect enough
cells for analysis, and ending at day 16 (Figure 2). We collected
data from fewer cells in the timecourse experiment than we had in
the previous experiment, but we confirmed the validity of the data
by collecting a new set of data at day 10 and comparing it to the
previous day 10 data, yielding median distances between c-Myc
and Igh of 2.78 and 2.75 mm, respectively, with a standard
deviation of 1.14 mm for both datasets (compare Figure 1C with
Figure 2A and Table S2 with Table S6). Our analysis of distance
at day 8, 10, 14, and 16 post-immunization show that the median
distance from c-Myc to Igh is not significantly shorter at any other
time point than at day 10 (Figure 2A, Tables S6 and S7). It is
therefore likely that c-Myc is at a greater distance on average from
Igh throughout the GC response than are the other non-Ig genes
assessed in this study. Furthermore, c-Myc and Igh are not within
0.5 mm of one another with any great frequency at any other time
point examined than at day 10 (Figure 2B). There was a smaller
percentage of measurements within 1.0 mm on day 10 relative to
days 8 and 14, but since the datasets were small the actual number
of measurements in range in each group was small, making
differences on this level difficult to interpret.
To confirm that our methods were sufficiently sensitive to detect
changes in locus proximity and to relate this to c-Myc,w e
replicated a previously published 3D-FISH experiment of
Osborne et al. [54] in which the distance between c-Myc and Igh
was examined in naı ¨ve B cells prior to and 5 minutes after ex vivo
stimulation with IL-4, a-CD40, and a-IgM. In close agreement
with their findings, we observed that the peak percentage of
measurements shifted from the 1.6–2.4 mm range in unstimulated
cells to the 0.8–1.6 mm range for 5 minute stimulated cells (data
not shown).
Distance between Non-Ig Loci and Igl
Igh is not the only mutating Ig gene in GC B cells. In this system,
the GC B cells responding to NP also express Igl, which mutates
and could affect mutation of nearby non-Ig genes. We therefore
measured the distance from the various genes of interest to the
nearest Igl allele. Since Igl and Bcl6 are both on chromosome 16,
4.6 Mb away from one another, we did not measure the distance
between Bcl6 and Igl. We found that, while deaminated genes
were on average closer to Igl than was b2m , they were not
significantly closer than Mef2b (Figure 3A, B). This was also true
for Igl-Igh distances. Therefore, as was the case with distances to
Igh, we do not observe a correlation between the level of AID
targeting of a non-Ig gene and its distance to Igl. This was true in
both GC B cells (Figure 3A and 3B, Tables S8 and S9) and naı ¨ve B
cells (Figure 3C and 3D, Tables S10 and S11).
Analysis of Human MYC Transgenic Mice
The data above show that there is no obvious relationship
between the distance to a mutating Ig gene and AID targeting of
a non-Ig gene. We therefore considered two alternative hypoth-
eses: the positioning of a gene at a particular location on
a particular chromosome influences its mutation/deamination
potential, or the coding and regulatory sequences intrinsic to each
gene determine its mutation/deamination potential and its
Proximity and Hypermutation in the Germinal Center
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test of these hypotheses, we made mice transgenic for human MYC
and studied the mutability of the human transgene in its new
location as compared to the endogenous c-Myc gene. We predicted
that if the second model is correct then as long as all relevant
coding and regulatory elements are included on the transgene, the
Figure 1. Distances of genes from Igh in germinal center and naı ¨ve B cells. (A) Examples of cells used in analysis. Collapsed z-stacks are
shown with nuclei outlined. Igh probes are shown in red and Bcl6 probes are shown in blue and green (colors overlap in example shown). In all
experiments, only cells in which both alleles for both genes under study were clearly visible were included in the analysis. Ig alleles were marked by
one probe and other genes were marked by either one or two probes. Cells whose nuclei were cut off by the edge of the picture were excluded. (B)
Schematic showing measurements taken from cells. Two cells and their nuclei are shown with red dots representing FISH probes to an Ig gene and
blue and/or green dots representing two different FISH probes to a non-Ig gene. Distances were measured from each allele of the gene of interest to
the closest allele of the Ig gene in question. (C and E) Scatter plots showing all distances (mm) measured from the gene marked on the x-axis to the
nearest Igh allele. The number of measurements taken is shown in parentheses above each data set and red bars mark the median. Two genes that
are not deaminated by AID are shown on the left, and 5 genes that are deaminated by AID are shown on the right. (C) Measurements taken from
splenic GC B cells 10 days post-immunization with 4-hydroxy-3-nitrophenylacetyl conjugated to chicken gamma globulin (NP-CGG). (E)
Measurements taken from splenic naı ¨ve B cells collected from the same spleen samples as those used in (C). (D and F) Bar graphs summarizing data
from (C) and (E) respectively. Bars represent the percentage of measurements in a dataset within 0.5 mm (dark blue) or 1.0 mm (blue green). The
number of measurements found in each distance range are shown in parentheses.
doi:10.1371/journal.pone.0039601.g001
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integration site. We chose human MYC to allow easy discrimina-
tion from mouse c-Myc in sequencing and expression analyses and
we chose a 94 kb bacterial artificial chromosome (BAC) with
34 kb of sequence upstream of MYC and 55 kb downstream to
increase chances of including all relevant transcriptional regula-
tory elements. Given that human MYC is mutated in an AID-
dependent fashion in some human B cell lymphomas [61] and
undergoes recurrent chromosomal translocations with IGH
[32,33], it, like mouse c-Myc, is likely a target of AID in GC B cells.
Microinjection of the MYC BAC yielded two founders (Myc31
and Myc24), both of which contained the entire MYC gene along
with 55 kb of downstream sequence and at least 21 kb of upstream
sequence (data not shown). By Southern blot, we estimated that
the Myc31 line contained 2 copies of the transgene and the Myc24
line contained 4 copies (Figure S3). Since we did not know where
the Myc31 and Myc24 transgenes had integrated, we performed
a 3D-FISH analysis of each transgene relative to Igh, Igl, Igk, and
endogenous c-Myc. This confirmed that all copies of the transgene
were integrated in one location in each line, and that neither
transgene integration site was linked to endogenous c-Myc or any
of the Ig genes (Figure S4). In GC B cells, the median distance
from Myc31 to Igh, Igl, Igk, and endogenous c-Myc was 2.62, 2.64,
2.55, and 2.42 mm, respectively, while for Myc 24, these numbers
were 2.73, 3.03, 3.11, and 2.67 mm (Figure S4, Tables S12 and
S13).
Because SHM requires transcription of its target genes [9], we
performed qRT-PCR to measure the relative transcription levels
of endogenous c-Myc and human MYC in various B cell samples
from bone marrow (Figure 4A), spleen (Figure 4B), and Peyer’s
patch (Figure 4C). We measured the expression in multiple tissues
because we wanted to assess not only the expression levels but also
expression patterns in B cell subsets, with the expectation that if all
important transcriptional control elements were contained in the
BAC, then the expression pattern of the human MYC transgene
would resemble that of endogenous c-Myc.
The expression pattern of endogenous c-Myc was similar in
Myc24, Myc31, and non-transgenic littermates, demonstrating
that the presence of the transgene did not affect the pattern or level
of endogenous c-Myc expression (data not shown), and data from
transgenic and non-transgenic littermates were therefore averaged
together in the analyses of c-Myc expression of Figure 4. In bone
marrow, the highest level of c-Myc expression was found in
immature B cells, followed by pro-B cells, and there was very little
expression in progenitor and pre-B cells. In both spleen and
Peyer’s patch, expression was higher in naı ¨ve B cells than it was in
GC B cells, in keeping with a previous analysis that showed that
GC B cells express only low levels of c-Myc [60].
Both MYC transgenes were expressed in bone marrow and
splenic B cells, but only Myc31 was expressed at detectable levels
in Peyer’s patch B cells (Figure 4). In all tissues, transgene
expression was deregulated relative to endogenous c-Myc. In bone
marrow, expression of Myc31 was highest in progenitor and
immature B cells and expression of Myc24 was highest in
progenitor and pro-B cells. Myc31 and Myc24 in spleen and
Myc31 in Peyer’s patch are expressed in GC B cells at levels at
least as high as in naı ¨ve B cells. The deregulation of the transgenes
might be caused by a number of factors including the absence of
important transcriptional regulatory sequences in the BAC, the
change in position of the gene, or the fact that the transgene is the
human version of c-Myc.
Given that the MYC transgenes were transcribed in at least some
GC B cell populations, it was possible that they would also be
targeted by AID and perhaps accumulate mutations. To examine
this, we studied the mutation of Myc31 and Myc24 in splenic GC
cells and Peyer’s patch GC cells on a WT or Msh2
2/2Ung
2/2
background. We sequenced a region 1 kb downstream of the MYC
P0 promoter, including more than 400 bp of the first exon. We
first performed sequence analysis of the transgenes on the WT
background in GC B cells from both spleen and Peyer’s patch
(Figure 5, red bars, Tables S14, S15, S16, and S17). As expected
[14], Bcl6 had the highest mutation frequency of the non-
immunoglobulin genes analyzed, and b2mdid not mutate. We
also confirmed very high mutation frequencies at Ig loci (either
VJl1 or the intron downstream of the Igh Jh4 gene) in these cells,
demonstrating that they had extensive exposure to the SHM
machinery (Tables S14, S15, S16, and S17). Endogenous c-Myc
mutated at a low frequency but was above background in some
cases, consistent with a previous analysis of c-Myc mutation in
Peyer’s patch GC B cells [14]. The MYC transgenes, however, did
not mutate at a significant frequency in either spleen or Peyer’s
patch WT GC B cells (Figure 5), with a total of <550,000 nt of
MYC sequence analyzed (Tables S14, S15, S16, and S17).
In a previous study, endogenous c-Myc was observed to mutate
at a low level in WT GC B cells and its targeting by AID only
became obvious when it was sequenced from Msh2
2/2Ung
2/2
double knockout GC B cells, where the mutation frequency was
Figure 2. Distance between c-Myc and Igh during the GC
response. (A) Scatter plot showing the distance (mm) between c-Myc
and Igh in GC B cells 8, 10, 14, and 16 days post-immunization with NP-
CGG. (B) Bar graphs summarizing data from (A). Data are presented as in
Figure 1.
doi:10.1371/journal.pone.0039601.g002
Proximity and Hypermutation in the Germinal Center
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39601increased almost 20-fold over that seen in WT GC B cells [14].
To determine whether this was also the case for the MYC
transgenes, we bred Myc31 and Myc24 onto an Msh2
2/2Ung
2/2
background and measured mutation in Peyer’s patch GC B cells
(Figure 5B, yellow bars, Tables S18 and S19). Bcl6, c-Myc, and
the Igh Jh4 intron accumulated a high mutation load in both the
Myc31 and Myc24 lines of mice, while b2mwas not mutated at
significant levels, consistent with previous findings [14]. Virtually
all mutations observed were C-to-T or G-to-A transition
mutations (data not shown), as expected for AID-mediated
mutation in the Msh2
2/2Ung
2/2 background [62]. Hence, the
GC B cells analyzed were exposed to significant levels of AID-
mediated cytidine deamination in the absence of repair. Despite
this, neither the Myc31 nor the Myc24 transgene accumulated
significant levels of mutation (Figure 5B). Given the lack of
expression of Myc24 in Peyer’s patch GC B cells (Figure 4C), we
expected that it would not mutate. The lack of mutation of the
Myc31 transgene, however, was notable because this transgene
was expressed about as well as endogenous c-Myc in Peyer’s
patch GC B cells (Figure 4C). Only two Myc31 mutations were
detected in over 173,000 nucleotides sequenced (Table S18),
yielding a mutation frequency (1.1610
25 mut/nt) that is below
the background frequency defined in AID
2/2 GC B cells
(1.6610
25 mut/nt). To confirm the lack of mutation of Myc31
on the Msh2
2/2Ung
2/2 background, we sequenced a different
1 kb region of this transgene that included the end of the MYC
first exon and most of the first intron, the region where mutation
frequencies are expected to be the highest [14,61]. Again we
found a total of only three Myc31 mutations in over 192,000 bp
sequenced from four independent Peyer’s patch GC B cell
samples, resulting in a mutation frequency of 1.56610
25
mutations/bp sequenced (Figure 5B, sample labeled ‘‘Int31’’;
Table S18, gene labeled ‘‘huMyc31 intron’’). We conclude that
the MYC transgenes were not deaminated by AID despite
substantial levels of deamination of other sites in the genome.
Figure 3. Distances of genes from Igl in germinal center and naı ¨ve B cells. (A and C) Scatter plots showing all distances (mm) measured from
the gene marked on the x-axis and the nearest Igl allele in (A) splenic GC B cells 10 days post-immunization with NP-CGG or (C) splenic naı ¨ve B cells
collected from the same spleen samples as those used in (A). (B and D) Bar graphs summarizing data from (A) and (C) respectively. Data are presented
as in Figure 1.
doi:10.1371/journal.pone.0039601.g003
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Proximity of Non-Ig genes to Ig Loci does not Correlate
with Deamination by AID
Our study of the nuclear localization of genes known to be
targeted by AID in GC B cells has revealed no correlation between
proximity to Ig genes and mutation. Even the two most highly
mutating loci in these GC B cells (Igl and Igh) are no closer to one
another, on average, than they are to the other loci examined. The
simplest and most likely explanation for our results is that
proximity to Ig genes does not contribute to a gene’s likelihood
of being mutated or deaminated by AID in normal mouse GC B
cells. This conclusion fits well with recent data indicating that
genes that acquire binding of replication protein A (RPA) as
a result of the action of AID do not show a tendency to be in close
proximity with Igh, as measured by chromosome conformation
capture experiments [63].
Our data, however, do not rule out all scenarios in which
proximity to Ig genes contributes to AID targeting or SHM. We
cannot exclude the possibility that the window of proximity to Ig
genes and mutation is either before or after the 10 days post-
immunization time-point studied, nor can we rule out the idea that
a regulated process moves non-Ig genes into close proximity of Ig
genes at specific time points during the GC response. We did
confirm that the median distance between c-Myc and Igh is
relatively constant from day 8–16 post-immunization and we
observed that that the distributions of distances from each non-Ig
gene to Ig lociare nearly identical. If the average relative location
of other genes is as stable as it is for c-Myc, the window of
proximity would need to be very early or late in the GC response,
or transient, for us to have missed the correlation.
A more likely scenario by which proximity to Ig loci could play
a role in mutation or deamination is if a second factor,
superimposed on proximity, determines the mutability of a gene.
Our data are notable in that, no matter what the gene pair
analyzed, the dataset contains at least a few close associations
between the Ig and non-Ig gene. It is possible that deamination/
mutation is most likely to occur on these alleles, but since all
datasets contain such associations, it is clear that low frequency
proximity to Ig loci is not sufficient to render a gene mutable.
However, our data are compatible with a requirement for
proximity if a second factor, such as E boxes in the vicinity of
the transcription start site, also contributes to mutability of a gene.
Indeed, E boxes were the only transcription factor binding motif
found to be enriched near the promoter in the most mutated
group of non-Ig genes in the Liu et al. study [14]. Further study of
SHM and the factors affecting it will elucidate whether proximity
works together with other mechanisms to determine mutability.
Our finding that all non-Ig genes analyzed come into close
proximity with the Ig loci analyzed in a small percentage of cells is
consistent with recent studies demonstrating the ability of the Igh
locus to engage in chromosomal translocations with many other
sites in the genome [63,64,65,66]. Of particular relevance is the
finding that eight different chromosomal sites interacted with and
Figure 4. Expression of endogenous c-Myc and transgenic MYC in B cells. (A, B, and C) Bar graphs represent the average expression level of
endogenous c-Myc (top row of each panel) or transgenic MYC (bottom row of each panel) relative to Hprt expression in the same sample for either
the Myc31 mouse line (left column in each panel) or the Myc24 line (right column in each panel). Error bars denote the standard error of the mean
(SEM). Cell populations analyzed were: (A) Progenitor cells (B220
2, CD43
2, IgM
-), Pro B cells (B220
+, CD43
+, IgM




Immature B cells (B220
+, CD43
2, IgM
+) sorted from bone marrow cells of 4–5 week old mice; (B) Naı ¨ve (B220
+, NIP
lo, FAS




+) sorted from spleens of mice immunized 16 days previously with NP-CGG; and (C) Naı ¨ve B cells (B220
+, CD19
+, PNA




hi) sorted from Peyer’s patches isolated from mice that had lived at least 1 month with non-autoclaved food and tap water. Data represent
an average of 2–6 experiments: Panel A top row, 4; panel A bottom row, 2; panel B top row, 6; panel B bottom row, 3; panel C top left, 6; panel C top
right, 4; panel C bottom left, 5; panel C bottom right, 3.
doi:10.1371/journal.pone.0039601.g004
Figure 5. Mutation level in Myc31 and Myc24 transgenic mice.
Bar graphs show mutations per 100,000 basepairs sequenced for
various non-immunoglobulin genes in germinal center (GC) B cells of
MYC transgenic mice. Data from the Myc31 line is shown on the left of
each graph and the Myc24 line on the right of each graph. Sequence
data from the first 1 kb downstream of the MYC P0 promoter is labeled
Myc31 or Myc24. Sequence data from the first intron (including the end
of the first exon) was done only in Msh2
2/2Ung
2/2 dko Myc31 mice
and is labeled Int31. A star above the bar indicates that the mutation
frequency is significantly (p,0.05) above the background frequency of
1.6 mutations per 100,000 basepairs sequenced reported by Liu et al.
[14] using a Chi-square test with Yate’s correction. A ‘‘0’’ in place of a bar
indicates that no mutations were found in all sequences analyzed. An
‘‘N’’ in place of a bar indicates that the sample was not sequenced. (A)
Splenic GC B cells sorted from Myc31 or Myc24 positive, B1-8
heterozygous mice immunized 16 days prior with NP-CGG. (B) Mutation
frequency in Peyer’s patch GC B cells isolated from either wild type mice
(red bars) or Msh2
2/2Ung
2/2 double knockout mice (yellow bars) aged
at least four months with non-autoclaved food and tap water.
doi:10.1371/journal.pone.0039601.g005
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antigen receptor loci in pre-B cell lines undergoing V(D)J
recombination [66]. The results of these studies and others
strongly suggest that the organization of chromosomes in the
nucleus is heterogeneous and that many (perhaps most) pairs of
expressed regions in the genome have a meaningful probability of
coming into close proximity [67].
We expect that our static picture of gene position in fixed cells is
a good representation of the distribution of gene arrangements in
live GC B cells. Although genes may loop out of their territories
[68,69,70] and in some cases chromosomes may be randomly
arranged in very early G1 phase [71], it appears that mammalian
chromosome territories are relatively stable and chromatin does
not diffuse widely [72,73]. While we cannot rule out the possibility
that genes move during purification and sorting for 3D-FISH after
the cells are removed from the GC, we tried to minimize changes
in gene position by following a methodology that maintains
nuclear architecture and spherical nuclei. One limitation of our
approach is revealed by recent studies that show that B cells
change shape significantly as they squeeze through small spaces
during movement in the GC [74,75]. Such dynamic cellular
deformations might alter intergenic spacing and would pre-
sumably not be captured by our analysis.
This study assessed whether mutation of a gene is determined by
the closeness of that gene to one of the mutating Ig genes. It did
not, however, assess other ways that nuclear localization could
play a role in mutation. It is possible that there are mutation hubs
for non-Ig genes but the hubs do not center around an Ig gene. It
is also possible that certain non-Ig genes have a propensity to be
near an Ig gene at an early time point prior to GC formation and
AID expression, as is the case for c-Myc and Igh in ex vivo activated
B cells [54]. Such genes could be marked for deamination/
mutation at that early time point and mutate later when AID is
expressed.
Position of c-Myc Relative to Igh
Genes that translocate frequently with one another have been
shown in other studies to have a tendency to be close to one
another [54,76,77,78]. It is known that c-Myc translocates with Igh,
Igl, and Igk. One study found that c-Myc moved closer to Igh
immediately after ex vivo activation [54] and we were able to
replicate this result. Another study of ex vivo activated B cells did
not find c-Myc and Igh nearer to one another after activation, but
did find that c-Myc is closer to Igh in B cells than it is in ES cells
[79]. Furthermore, a study of MYC relative to all three Ig loci in
a human B cell line found that it is closer to IGL and IGH, to which
it translocates most, than it is to IGK [80].
These data, together with the results of two recent genome-wide
translocation analyses [63,66], are consistent with a model in
which proximity contributes to translocation frequency. Because
MYC-IG translocations are a common feature of GC derived
lymphoid tumors in humans, it is important to understand the
mechanisms that lead to these translocations. One possibility is
that they are favored by close proximity between MYC and Ig loci
in GC B cells. Our data provide the first direct test of this idea, and
show that, contrary to this simple expectation, c-Myc is actually the
most distant from Igh of the seven loci tested in GC B cells
(Figure 1C and 1D) and is not significantly closer to Igh than the
other genes tested in naı ¨ve B cells (Figure 1E and 1F). Our study of
non-Ig genes relative to Igl gave a similar result; in both GC and
naı ¨ve B cells c-Myc was as far or farther from Igl than most of the
other loci examined (Figure 3).
Hence, we have no evidence that c-Myc-Igh or c-Myc-Igl
translocations might be especially favored in GC B cells due to
unusually close spatial proximity between c-Myc and these Ig loci.
This is consistent with the recent finding that c-Myc and Igh do not
come into close physical proximity at a notably high frequency in
ex vivo activated splenic B cells [63]. Indeed, although we found c-
Myc to be significantly closer to Igh and Igl than it is to Igk in naı ¨ve
B cells, consistent with previous work on a human B cell line [80],
we observed that this difference is lost in GC B cells (Figure S5,
Table S20, S21, S22, and 23). However, our data do not preclude
a requirement for close proximity for translocation. We do detect
very close proximity between c-Myc and Ig loci in a small fraction
of GC B cells and it is possible that c-Myc-Ig translocations are
favored in this subset of cells. Also, as noted above, others have
found that c-Myc is closer to Igh in B cells than in non-B cells [79],
a comparison we have not made, and this might enhance the
probability of c-Myc-Igh translocations in the B lineage.
It remains to be determined whether c-Myc-Igh or c-Myc-Igl
translocations occur with a particularly high frequency in GC B
cells. Relevant to this is the finding that when c-Myc coding
sequences are replaced by those of N-myc, N-myc becomes
a frequent Igh translocation partner in pro-B cell lymphomas in
mice lacking Ligase 4 and p53 [53]. This result argues that there
are mechanistic features of the c-Myc locus that predispose it to
translocate with Igh in pro-B cells. It is possible that there is
a similar predisposition of c-Myc to translocate with Ig loci in GC B
cells, although clear evidence for this is lacking. The appearance of
MYC-Ig translocations in GC derived B cell tumors could simply
be the result of strong cellular selection. In this regard, two recent
genome-wide studies failed to detect c-Myc as a hotspot for
translocation with a defined DSB in the Igh locus in ex vivo
activated B cells expressing physiological levels of AID [64,65],
although one study found c-Myc to be a translocation hotspot when
AID was overexpressed [65]. We propose that if c-Myc is a favored
translocation partner for Igh or Igl in GC B cells, this is due to
features of the c-Myc locus other than an unusually close proximity
to these Ig loci. An obvious predisposing feature would be the fact
that c-Myc is targeted by AID.
Mutation and Expression of Human MYC Transgenes
To assess whether the chromosomal location of MYC affects its
mutation we made mice transgenic for human MYC.I fMYC
contains intrinsic sequence features that render it a good AID
target, then it should be a good AID target as long as it is
expressed no matter where it integrates in the genome. If,
however, the particular genomic location of endogenous MYC is
crucial for AID targeting, then it might not be targeted in other
locations. Mutation and expression analysis on two MYC trans-
genic mouse lines indicated that MYC is not mutated or even
deaminated in two new locations despite the fact that it is
expressed in splenic GC B cells and, in the case of Myc31, also
expressed in Peyer’s patch GC B cells.
From this we conclude that the sequences contained in the MYC
BAC used in our experiments do not contain sufficient information
to target AID to the transgene in mouse GC B cells. There could
be several explanations for this. First, it might be that the position
of the MYC locus in the genome is critical for AID targeting and
this positioning is lost in the MYC transgenes. Second, the human
MYC locus might contain intrinsic sequence features critical for
AID targeting, but those sequence features were either not
included in the BAC transgene or were not able to exert their
activity in mouse GC B cells. The failure of the MYC transgenes to
be expressed in a pattern that mimics endogenous c-Myc strongly
suggests that important transcriptional regulatory elements were
missing from the BAC or did not function properly in mouse GC B
cells. Transgenic mice created in another lab using a rat BAC
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expression relative to the endogenous c-Myc gene (R. Casellas,
personal communication). The fact that c-Myc BACs, even from
rat, which is more closely related to mouse than is man, were
unable to express normally makes the importance of distant
elements or nuclear positioning more likely. Third, we cannot rule
out the possibility that human and mouse MYC loci obey different
rules in relation to AID targeting. Mouse c-Myc is one of the
strongest known non-Ig gene targets for AID in normal GC B
cells, although few mutations accumulate due to high-fidelity
repair [14]. Because the breakpoints in human MYC translocations
often lie in its first exon or intron, precisely where AID would be
expected to be most active [61], it is reasonable to think that MYC
is also a strong AID target in normal human GC B cells. This,
however, remains to be directly demonstrated. Previous sequenc-
ing of MYC in human peripheral memory B cells showed no
significant level of mutation [10,81], but it is possible that human
MYC, like mouse c-Myc, is primarily repaired in a high-fidelity
manner. It is worth noting that MYC is significantly mutated by
AID in certain human B cell lymphomas [61].
In summary, while our data argue against a role for proximity of
non-Ig genes to Ig loci in determining AID targeting or the
accumulation of mutations in mouse GC B cells, they do not
support strong conclusions regarding the question of whether the
genomic location of human MYC (and by extension, mouse c-Myc)




All mouse work in this study was performed in accordance with
the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. All procedures were approved by the
Institutional Animal Care and Use Committee of Yale University
(protocol number 2009-07610) and every possible effort was made
to minimize suffering.
Generation of Transgenic Mice
Transgenic mice were made by microinjection of embryos with
BAC CTD-3056O22 (Invitrogen), which contains the human
MYC gene. BAC DNA was isolated using a Qiagen large construct
kit and then linearized overnight and run on a pulse field gel in
0.9% low melting point agarose (Seaplaque) in TAE. The BAC
DNA was then purified from the gel by melting, digesting
overnight with 10 u b-agarase, spinning to remove large particles,
and separating larger DNA fragments using a Millipore ultrafree-
MC filter with a 30 kD molecular weight cut off. The DNA was
microinjected at the Yale Animal Genomics Services facility.
Potential founders were screened first by PCR and then confirmed
by Southern blot. Founders were analyzed by PCR to determine
how many kb of upstream and downstream sequence had
integrated as part of the transgene. The two transgenic mouse
lines were maintained in mouse facilities at Yale Medical School
by mating with Balb/c WT mice from Jackson Laboratories.
Transgene positive mice were also bred with B1-8 knockin mice to
generate B1-8 heterozygous Myc transgene positive mice. Each
transgenic line was also crossed with Msh2
+/2Ung
2/2 mice and







2/2 mice. All primers used for Southern
blot probes, typing, and determination of BAC integration are
available upon request.
3D-FISH
For each experiment, five B1-8 knockin heterozygous mice were
immunized intraperitoneally with 25 mg NP-CGG precipitated in
alum. 10 days later spleens were removed and red blood cells were
lysed. Some of the cell suspension was saved for sorting of naı ¨ve B
cells. From the rest, GC B cells were negatively selected using
a custom order Easysep kit for B cell enrichment without a-CD43
(Stemcell). 1:800 a-CD38 (BD cat# 553762) conjugated to biotin
was added with the antibody mix provided by Stemcell. Cells were
stained with NIP conjugated to PE (conjugated in lab), a-FAS
(CD95) PE-Cy7 (BD cat# 557653), and a-B220 A700 (BD cat#
557957), sorted, and used immediately for 3D-FISH. BACs to be
used for fluorescent probes were prepared using a Qiagen large
construct kit and then labeled using a nick translation mix (Roche
cat# 11745808910) and either A488-5-dUTP (Invitrogen cat# C-
11397), A568-5-dUTP (Invitrogen cat# C-11399), or Cy5-dUTP
(GE healthcare cat# PA55026). All BACs used for 3D-FISH are
listed in Table S23. The nick translation reaction was allowed to
progress at 16uC until most of the DNA was 100-600 bp in size.
Probes were filtered for 2 hours on 0.025 mm filters (Millipore
cat# VSWP02500), and precipitated with 9.9 mg salmon sperm
DNA, 0.9 mg mouse Hyblock DNA, and 0.9 mg COT1 DNA for
every 1 mg probe DNA. All probes to be used on a slide were
precipitated together, resuspended in a dextran sulphate hybrid-
ization mix, heated at 95uC for 5 minutes, and then left at 37uC
for about 1 hour until hybridization. Interphase FISH was done as
previously reported [82]. Briefly, cells attached to poly-L-lysine
coated coverslips were put in various solutions: 0.1% triton X and
0.5% glutaraldehyde for 30 minutes, 4% (w/v) sodium borohy-
dride for 2615 minutes, PBS with 5% FBS and 5% NGS for 30
minutes, ethylene glycol bis(succinimidyl succinate) for 30 minutes
at 37uC, and 100 mg/ml RNaseA in 2X SSC for 1 hour. The
coverslips were then put in 1N NaOH for exactly 2 minutes,
washed in ice cold PBS, and hybridized with probe overnight at
37uC in a wet chamber. After hybridization coverslips were
washed in SSC and mounted on slides with Vectashield with
DAPI.
Microscopy and Analysis of FISH Data
FISH slides were analyzed using a Leica SP5 scanning confocal
microscope with a 63X 1.4 oil lens. Scans were done in one
direction at a speed of 400 Hz and 4 frames were averaged for
each XY picture. In Z, a picture was taken every 0.18 mmt o
create a Z stack. The software Volocity was used to find the nuclei
and probe spots and to obtain the X, Y and Z centroid coordinates
of each. The Volocity output was analyzed with a homemade
Stata program that calculated the distances between each of the
centroids associated with one cell. Kolmogorov-Smirnov tests were
done on the website http://www.physics.csbsju.edu/stats/KS-
tests.html.
Expression Analysis
Peyer’s patch. Peyer’s patches were removed from two to
four euthanized mice that had been maintained on non-
autoclaved food and water. Germinal center B cells were sorted
based on staining with B220-cychrome (BD), CD19-PE (BD), and
PNA-FITC (Vector Labs). The B220
+, CD19
+ and PNA lo naı ¨ve
B cells were also sorted. Bone marrow: Bone marrow cells were
collected from the leg bones of euthanized 4–5 week old mice. Red
blood cells were lysed and the remaining cells were stained with a-
B220-PerCP, a-CD43-PE, and a-IgM-APC (all from BD) and four














+) cells. Spleen: Spleens were
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were lysed. The white blood cells were separated using a MACS
kit for depletion of non-B cells and the B cell fraction was
resuspended in B cell media and activated with LPS and IL-4 for
2–3 days. All samples: RNA was prepared from cells using the
Qiagen RNA isolation kit and Qiashredder. The eluate was rerun
through the same column to increase yield. RNA concentration
was measured using a NanoDrop spectrophotometer. RNA was
treated with DNase (Invitrogen) and then used to make cDNA
with Superscript II RT (Invitrogen), random hexamer primers,
and RNaseOUT (Invitrogen). Approximately equal amounts of
RNA were used for each reaction. qPCR was done in duplicate
with primers spanning a large intron and a TaqMan 5’FAM/
3’BHQ-1 probe (Biosearch) complementary to the expected
product. All initial concentrations were calculated by comparison
to a previously tested gene specific standard. 25 ml reactions using
Qiagen HotStarTaq were allowed to proceed for 40 cycles on
a Stratagene MX3000P thermal cycler.
Sequence Analysis
Peyer’s patch B cell sorts for sequence analysis were done as for
expression analysis except that mice were aged with non-
autoclaved food and water for at least 4 months. We were also
able to sort Peyer’s patch B cells from only one to three mice per
group since the Peyer’s patches were usually larger in both size and
number in the aged mice. Spleen sorts for sequence analysis were
done as for FISH except that spleens were removed on day 16
post-immunization. The preparation of DNA, PCR amplification
and TOPO cloning were all done as previously reported [14].
Clones were picked into 96 or 384 well plates and sent for
sequencing at Beckman Coulter. Sequence analysis was performed
as reported [14] except that redundant mutations were not scored.
Supporting Information
Figure S1 Representative FACS set up for collecting
splenic B cells. Live cells were selected in the side scatter (SSC-
A) vs. forward scatter (FSC-A) plot (A). Doublets and clumps were
excluded in the side scatter width (SSC-W) vs. side scatter height
(SSC-H) and forward scatter width (FSC-W) vs. forward scatter
height (FSC-H) plots (B). Cells were gated for B220 expression (C),
as well as FAS expression, and NIP binding (D). Germinal center
B cells (FAS
+NIP
+) were sorted from spleen samples that had been
magnetically separated to remove non-B cells and naı ¨ve B cells.
Naı ¨ve B cells (FAS
-NIP
-) were sorted from unmanipulated spleen
samples.
(PDF)
Figure S2 Mutation frequencies in GC B cells from
spleen and Peyer’s patch. Bars represent mutations per
100,000 basepairs sequenced from various non-immunoglobulin
genes in germinal center (GC) B cells. The actual number of
mutations found in each gene is shown in parentheses above each
bar. A star above the bar indicates that the mutation frequency
was determined to be significantly (p,0.05) above the background
frequency of 1.6 mutations per 100,000 basepairs sequenced
reported by Liu et al. [14] using a Chi-square test with Yate’s
correction. (A) Splenic GC B cells were sorted from B1-8
heterozygous (het) mice immunized 16 days prior with 4-
hydroxy-3-nitrophenylacetyl conjugated to chicken gamma glob-
ulin (NP-CGG). (B) Mutation frequencies in Peyer’s patch B cells
as reported in Liu et al. [14].
(PDF)
Figure S3 Southern blot of transgenic mouse DNA to
confirm the presence of the human MYC transgene and
estimate copy number. Myc24
+ (24+), and Myc31
+ (31+) DNA
were compared to human DNA (hum) and non-transgenic
littermate DNA (24 LM and 31 LM), as indicated above the lanes.
TheagarosegeloftheBglIIdigestedDNAisshownontheright,and
the hybridized blot is shown on the left. The 5 and 6 kb marker
bands of the agarose gel are indicated. Two identical southern blots
were analyzed and Myc24 was estimated to contain 4 copies of the
transgene and Myc31 was estimated to contain 2 copies.
(PDF)
Figure S4 The distance from the huMyc31 or huMyc24
transgenes to Ig genes and endogenous c-Myc. Scatter
plots are presented showing all distances (mm) measured from the
(A) Myc31 or (B) Myc24 transgene to the nearest allele of the gene
marked on the x-axis. The number of measurements taken is
shown in parentheses above each data set and red bars mark the
median. Data are presented as in Figure 1.
(PDF)
Figure S5 The distance from c-Myc to Ig loci in
germinal center and naı ¨ve B cells. Scatter plots show all
distances (mm) measured from c-Myc to the nearest allele of the
gene marked on the x-axis in splenic GC or naı ¨ve B cells 10 days
post-immunization with NP-CGG. Data for c-Myc relative to Igh
and c-Myc relative to Igl are the same as those shown in Figures 1
and 3 respectively. Data are presented as in Figure 1.
(PDF)
Table S1 Mutation in B1-8 het splenic GC cells. Table
shows the mutations (Mut) per base pair sequenced (bp) for various
genes (Gene) in each splenic GC cell sample (Sample). The
mutations and number of base pairs sequenced are added together
for each gene and the mutation frequency (Frequency) is
calculated by dividing the total number of mutations by the total
number of base pairs sequenced. A ‘‘Yes’’ in the p,0.05 column
indicates that the mutation frequency is statistically above
background (p,0.05) as determined by a Chi-square test with
Yate’s correction. The background mutation level of 1.6 mutations
per 100,000 base pairs sequenced was determined in Liu et al.
[14].
(PDF)
Table S2 Summary of FISH data for genes relative to
Igh in GC B cells. Supporting data for graphs in Figure 1C and
1D. For each gene analyzed relative to Igh the number of slides
analyzed (Slides), number of measurements taken (Number),
median distance (Median), mean distance (Mean), standard
deviation (St. Dev.), and 95% confidence interval (95% conf.
int.) are shown. Individual slides came from independent
experiments. Only cells in which both alleles of both loci of
interest were clearly labeled by FISH probes were included in
analysis. Two measurements were taken from each cell.
(PDF)
Table S3 KS tests of FISH data for distance to Igh in GC
cells. Kolmogorov-Smirnov (KS) test results derived from the
datasets of Figure 1C and 1E. KS tests, which compare dataset
distributions, were done using the website http://www.physics.
csbsju.edu/stats/KS-test.html. Datasets on the left were compared
with datasets on the top. The p value is shown, and for any
comparison that led to a p value less than 0.1, the corresponding D
value is shown in parentheses. D is the maximum vertical distance
between the two cumulative fraction plots and indicates the
magnitude of the difference between the two distributions.
(PDF)
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Igh in naı ¨ve B cells. Supporting data for graphs in Figure 1E
and 1F. See the legend of Table S2 for a full description.
(PDF)
Table S5 KS tests of FISH data for genes relative to Igh
in naı ¨ve cells. KS test results comparing the datasets in
Figure 1E and 1F. See the legend of Table S3 for a full description.
(PDF)
Table S6 Summary of FISH data for c-Myc relative to
Igh at various timepoints. Supporting data for graphs in
Figure 2A and 2B. See the legend of Table S2 for a full
description.
(PDF)
Table S7 KS tests of FISH data for c-Myc relative to Igh
at various timepoints. KS test results comparing the datasets
in Figure 2A and 2B. See the legend of Table S3 for a full
description.
(PDF)
Table S8 Summary of FISH data for genes relative to
Igl in GC cells. Supporting data for graphs in Figure 3A and 3B.
See the legend of Table S2 for a full description.
(PDF)
Table S9 KS tests of FISH data for genes relative to Igl
in GC cells. KS test results comparing the datasets used in
Figure 3A and 3B. See the legend of Table S3 for a full
description.
(PDF)
Table S10 Summary of FISH data for genes relative to
Igl in naı ¨ve cells. Number of slides analyzed, number of
distances measured, and statistical analysis for each of the datasets
included in Figure 3C and 3D. See the legend of Table S2 for a full
description.
(PDF)
Table S11 KS tests of FISH data for genes relative to Igl
in naı ¨ve cells. KS test results comparing the datasets used in
Figure 3C and 3D. See the legend of Table S3 for a full
description.
(PDF)
Table S12 Summary of FISH data for Myc31 relative to
other genes. Supporting data for graph in Figure S4A. See the
legend of Table S2 for a full description.
(PDF)
Table S13 Summary of FISH data for Myc24 relative to
other genes. Supporting data for graph in Figure S4B. See the
legend of Table S2 for a full description.
(PDF)
Table S14 Mutation in B1-8 het Myc31
+ splenic GC
cells. Supporting data for left side of graph in Figure 5A. See the
legend of Table S1 for a full description.
(PDF)
Table S15 Mutation in B1-8 het Myc24
+ splenic GC
cells. Supporting data for right half of graph in Figure 5A. See the
legend of Table S1 for a full description.
(PDF)
Table S16 Mutation in Myc31
+ Peyer’s patch GC B cells.
Supporting data for red bars in the left half of the graph in
Figure 5B. See the legend of Table S1 for a full description.
(PDF)
Table S17 Mutation in Myc24
+ Peyer’s patch GC B cells.
Supporting data for red bars in the right half of the graph in
Figure 5B. See the legend of Table S1 for a full description.
(PDF)




patch GC B cells. Supporting data for yellow bars in the left half
of Figure 5B. See the legend of Table S1 for a full description.
(PDF)




patch GC B cells. Supporting data for yellow bars in the right
half of the graph in Figure 5B. See the legend of Table S1 for a full
description.
(PDF)
Table S20 Summary of FISH data for c-Myc relative to
Igk. Supporting data for Igk data in Figure S5. See the legend of
Table S2 for a full description.
(PDF)
Table S21 KS tests of FISH data for c-Myc relative to Ig
loci in GC B cells. KS test results comparing the GC cell
datasets in Figure S5. See the legend of Table S3 for a full
description.
(PDF)
Table S22 KS tests of FISH data for c-Myc relative to Ig
loci in naive B cells. KS test results comparing the naı ¨ve cell
datasets in Figure S5. See the legend of Table S3 for a full
description.
(PDF)
Table S23 BACs used for FISH analysis. BACs used for
FISH analysis are listed (BAC Name) along with their accession
numbers (Accession), size in kb (Size), and position (Relative
position) with reference to the gene of interest (Gene). The
chromosome number on which each gene is found (Chr) is listed,
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